Advanced in Spontaneous Coronary Artery Dissection (SCAD)

Marilucy Sublet-Lopez

Bobigny, FR 
Advanced in Spontaneous Coronary Artery Dissection (SCAD)
Bobigny, FR 
OverviewLocationsClinical Research

Overview

Marilucy Sublet-Lopez practices in Bobigny, France. Sublet-Lopez is rated as an Advanced expert by MediFind in the treatment of Spontaneous Coronary Artery Dissection (SCAD). Their top areas of expertise are Hypertension, Fibromuscular Dysplasia (FMD), Spontaneous Coronary Artery Dissection (SCAD), and COVID-19.

Their clinical research consists of co-authoring 41 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Spontaneous Coronary Artery Dissection (SCAD).

Locations

Bobigny, France
Other Locations
Avicenne, France
Nancy, France
Paris, France
Saint-denis-de-palin, France
Lyon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study
Prevention of Symptomatic Venous Thromboembolism by Low Molecular Weight Heparin in Hospitalized Medical Patients Aged 70 Years and Older : a Randomized Placebo-Controlled Study The SYMPTOMS (SYstematic Elderly Medical Patients Thromboprophylaxis : Efficacy on Symptomatic OutcoMeS) Study
Enrollment Status: Completed
Publish Date: July 05, 2022
Intervention Type: Drug
Study Drug: Enoxaparin
Study Phase: Phase 3
ESCORT-HU : European Sickle Cell Disease Cohort - Hydroxyurea
ESCORT-HU : European Sickle Cell Disease Cohort - Hydroxyurea
Enrollment Status: Completed
Publish Date: March 19, 2020
Intervention Type: Drug
View 1 Less Clinical Trial

41 Total Publications

Comparison of Prophylactic and Therapeutic Doses of Anticoagulation for Acute Chest Syndrome in Sickle Cell Disease: The TASC Randomized Clinical Trial.
Comparison of Prophylactic and Therapeutic Doses of Anticoagulation for Acute Chest Syndrome in Sickle Cell Disease: The TASC Randomized Clinical Trial.
Journal: American journal of respiratory and critical care medicine
Published: April 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Sublet-Lopez's expertise for a condition
ConditionClose
      View All 8 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile